#HVO hVIVO PLC – Appointment of Non-Executive Chair September 1, 2025 – Posted in: hVIVO (HVO)

Appointment of Non-Executive Chair hVIVO plc (AIM: HVO), a full-service Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, confirms that, further to its announcement on 29 July 2025, Shaun Chilton has today joined the Board of Directors as Non-Executive Chair with immediate effect.   Shaun brings substantial sector-relevant experience and expertise to the Board, underpinned by a track record of delivering strong growth in sales and enterprise value. He brings…

Continue reading

#HVO hVIVO PLC – Proposed appointment of Chair July 29, 2025 – Posted in: Blog, hVIVO (HVO)

hVIVO plc (AIM: HVO), a full-service Contract Research Organisation and the world leader in human challenge clinical trials, announces the appointment of Shaun Chilton as Non-Executive Chair, subject to successful completion of customary due diligence procedures by the Company’s Nominated Adviser. It is intended that Shaun will join the Board on 1 September 2025. Shaun will bring substantial sector-relevant experience and expertise to the Board, underpinned by a track record of delivering strong growth in sales…

Continue reading

Markets and Stocks January 2023 – Doc Holliday talks to Alan Green January 19, 2023 – Posted in: Blog, hVIVO (HVO), Poolbeg Pharma (POLB)

Markets and Stocks January 2023 – Doc Holliday talks to Alan Green. We look at Doc’s new Twitter Spaces cast, before turning to stocks: 04:00 Avacta #AVCT | 06:00 Hvivo #HVO & Poolbeg Pharma #POLB | 08:15 – Longboat Energy #LBE / Energy stocks | 11:26 – Cadence Minerals #KDNC | 14:55 – Mining Companies | 17:40 – Argo Blockchain #ARB | 21:20 – Revolution Bars #RGB | 26:26 – Over the next few months |…

Continue reading

Alan Green talks COVID stocks Novacyt #NCYT), Synairgen #SNG, Avacta #AVCT, plus Blue Prism #PRSM & Capita #CPI on the UK Investor Magazine podcast November 12, 2020 – Posted in: Blog

The UK Investor Magazine Podcast is joined by Alan Green for a run down of the dramatic moves in markets this week and exploration of scenarios going into the end of 2020. The Biden Presidential victory has been overshadowed by news from Pfizer had a breakthrough in the fight against COVID-19 with a vaccine demonstrating 90% effectiveness. We look at the sharp rally in markets and question the sustainability going forward. We discuss Novacyt (NCYT),…

Continue reading